USPTO serial 90612233
CONNECTED ANALYTICS
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jan 7, 2025
- Examiner
- LE, KIEU-NHI NGOC
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with CONNECTED ANALYTICS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Susan M. Natland
Susan M. Natland Baker & Hostetler LLP600 Anton Blvd, Suite 900Costa Mesa, CA 92626-7221United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 035 | Providing an online portal featuring educational, consumer information in the fields of nucleic acid sequencing, genotyping, genetic testing, and genetics | ACTIVE | Jan 28, 2021 |
| 037 | Technical support services, namely, technical advice related to the repair of computer hardware; Technical support services, namely, troubleshooting computer hardware and genetic analysis machinery problems in the fields of nucleic acid sequencing, genotyping, genetic testing, and genetics | ACTIVE | Jan 28, 2021 |
| 042 | Online, non-downloadable computer software for analyzing genetic code for use in the fields of nucleic acid sequencing, genotyping, genetic testing, and genetics; Online, non-downloadable computer software for analysis of sequencing data in the fields of nucleic acid sequencing, genotyping, genetic testing, and genetics; Online, non-downloadable computer software for analyzing next-generation sequencing (NGS) data in the fields of nucleic acid sequencing, genotyping, genetic testing, and genetics; Online, non-downloadable computer software for capturing, storing, accessing, displaying, sharing, compressing, migrating, and managing digital files in the field of genomics; Online, non-downloadable computer software for processing, visualizing, storing, sharing, and manipulating next-generation sequencing (NGS) data in the fields of nucleic acid sequencing, genotyping, genetic testing, and genetics; Online, non-downloadable computer software that enables users to store, access, manage, analyze and share data in the field of genomics; Software as a service (SaaS) and Platform as a service (PaaS) services featuring software and software platforms for analyzing genetic code for use in the fields of nucleic acid sequencing, genotyping, genetic testing, and genetics; Software as a service (SaaS) and Platform as a service (PaaS) services featuring software and software platforms for analysis of sequencing data in the fields of nucleic acid sequencing, genotyping, genetic testing, and genetics; Software as a service (SaaS) and Platform as a service (PaaS) services featuring software and software platforms for analyzing next-generation sequencing (NGS) data in the fields of nucleic acid sequencing, genotyping, genetic testing, and genetics; Software as a service (SaaS) and Platform as a service (PaaS) services featuring software and software platforms for for capturing, storing, accessing, displaying, sharing, compressing, migrating, and managing digital files in the field of genomics; Software as a service (SaaS) and Platform as a service (PaaS) services featuring software and software platforms for processing, visualizing, storing, sharing, and manipulating next-generation sequencing (NGS) data in the fields of nucleic acid sequencing, genotyping, genetic testing, and genetics; Software as a service (SaaS) and Platform as a service (PaaS) services featuring software and software platforms for collecting, storing, analyzing, sharing and reporting biological, genetic, clinical, medical, and diagnostic information, and for sample tracking and managing projects, laboratory workflow and data, all of the foregoing for use in the fields of nucleic acid sequencing, genotyping, genetic testing, and genetics; Providing scientific analysis in the field of next-generation sequencing (NGS) in the fields of nucleic acid sequencing, genotyping, genetic testing, and genetics; Providing scientific analysis of genomic data; Technical support services, namely, troubleshooting of computer software problems and providing software updates, enhancements and modifications for software and hosted software in the fields of nucleic acid sequencing, genotyping, genetic testing, and genetics; Technical support services, namely, infrastructure management services for monitoring, administration and management of software based cloud computing information technology and computer application software systems in the fields of nucleic acid sequencing, genotyping, genetic testing, and genetics; Genetic DNA and RNA scientific analysis and reporting services thereto in the nature of providing reports in the fields of nucleic acid sequencing, genotyping, genetic testing, and genetics for scientific and research purposes; Biological material analysis being scientific analysis services in the fields of nucleic acid sequencing, genotyping, genetic testing, and genetics; Hosting an online network service being a server on a global computer network featuring technology that enables users to store, analyze and share data in the fields of nucleic acid sequencing, genotyping, genetic testing, and genetics; Installation and maintenance of computer software and database applications for others for use in the fields of nucleic acid sequencing, genotyping, genetic testing, and genetics; Updating of computer software for others in the fields of nucleic acid sequencing, genotyping, genetic testing, and genetics; Cloud hosting provider services featuring technology for storing, analyzing and sharing information in the fields of nucleic acid sequencing, genotyping, genetic testing, and genetics; Providing an online network service being a server on a global computer network featuring technology that enables users to store, access, manage, analyze and share data for use in the fields of nucleic acid sequencing, genotyping, genetic testing, and genetics; Design and development of databases for others for collecting, storing, analyzing, and reporting biological information in the fields of nucleic acid sequencing, genotyping, genetic testing, and genetics; Database design and development in the fields of nucleic acid sequencing, genotyping, genetic testing, and genetics; Computer diagnostic services featuring online, non-downloadable software for use in analyzing and sequencing nucleic acids and other biological molecules in the fields of nucleic acid sequencing, genotyping, genetic testing, and genetics; Cloud computing featuring software for analyzing genetic code for use in the fields of nucleic acid sequencing, genotyping, genetic testing, and genetics; Cloud computing featuring software for analyzing and sequencing nucleic acids and other biological molecules in the fields of nucleic acid sequencing, genotyping, genetic testing, and genetics; Providing on-line non-downloadable computer search engine software in the fields of nucleic acid sequencing, genotyping, genetic testing, and genetics; Providing an online portal featuring educational, scientific information in the fields of nucleic acid sequencing, genotyping, genetic testing, and genetics; Cloud computing featuring software for analyzing genetic code in the fields of nucleic acid sequencing, genotyping, genetic testing, and genetics; Providing online computer databases featuring scientific information based on the results of genetic testing; Software as a service (SaaS) and Platform as a service (PaaS) services featuring software and software platforms for use in data management, data compression, data migration, data storage, data analysis, and report generation, all in the fields of nucleic acid sequencing, genotyping, genetic testing, and genetics; Online, non-downloadable computer software for encrypting data and files in the fields of nucleic acid sequencing, genotyping, genetic testing, and genetics; Software as a service (SaaS) services featuring non-downloadable software for analyzing genetic code for use in the fields of nucleic acid sequencing, genotyping, genetic testing, and genetics; Online non-downloadable computer software for analyzing genetic code for use with genomic data; Genetic analysis and reporting services thereto for scientific and research purposes; Nucleic acid identification and sequencing and analysis services for scientific and research purposes; Providing online, non-downloadable computer software for analyzing genetic code in the fields of nucleic acid sequencing, genotyping, genetic testing, and genetics; Genome sequencing and analysis services for scientific and research purposes; Computer services, namely, providing online, non-downloadable software for analyzing genetic code in the fields of nucleic acid sequencing, genotyping, genetic testing, and genetics; Computer diagnostic services in the fields of nucleic acid sequencing, genotyping, genetic testing, and genetics; Technical support services, namely, troubleshooting computer software problems in the fields of nucleic acid sequencing, genotyping, genetic testing, and genetics; Providing temporary use of online, non-downloadable cloud based software for analyzing genetic code for use in the fields of nucleic acid sequencing, genotyping, genetic testing, and genetics; Providing temporary use of online, non-downloadable cloud based software for providing security and privacy in the fields of nucleic acid sequencing, genotyping, genetic testing, and genetics; Software as a service (SaaS) and Platform as a service (PaaS) services featuring software platforms for enabling multi-omics analysis; Software as a service (SaaS) and Platform as a service (PaaS) services featuring software and software platforms for analyzing genetic code for use in the field of data science; Providing temporary use of online, non-downloadable graphical user interface software in the fields of nucleic acid sequencing, genotyping, genetic testing, and genetics; Computer services, namely, providing on-line non-downloadable software for creating and sharing interactive graphical user interfaces in the nature of dashboard visualizations in the fields of nucleic acid sequencing, genotyping, genetic testing, and genetics; Software as a service (SaaS) services, featuring software for a user interface designed to enable access to application and server infrastructure performance management with a dashboard for software application and computing infrastructure performance metrics and events for aggregation, manipulation, graphing and reporting in the fields of nucleic acid sequencing, genotyping, genetic testing, and genetics; Software as a service (SaaS) services featuring software for enabling user interaction with genomics data via a graphical user interface; Software as a service (SaaS) services featuring software for providing users the opportunity to interactively explore integrated genomic data and associated clinical data; Platform as a service (PaaS) services featuring computer software platforms for providing decentralized computing services in the nature of securing and protecting electronic data and automating workflows in the fields of nucleic acid sequencing, genotyping, genetic testing, and genetics; Online non-downloadable graphical, command line, menu driven, form based, and natural language user interface software for use in the fields of nucleic acid sequencing, genotyping, genetic testing, and genetics; Online non-downloadable software for user interfaces, dashboards, and command lines for use in the fields of nucleic acid sequencing, genotyping, genetic testing, and genetics; Application service provider (ASP) featuring software for providing access to multiple databases that contain aggregated results of genotyping and genetic, genomic, molecular, and biomarker data; Providing scientific analysis and informational reports thereto based upon results of genetic, genomic, molecular, and biomarker data; Software as a service (SaaS) services featuring software for research and analysis of biomedical data; Application service provider featuring application programming interface (API) software for others to build and market genetic, genomic, molecular, and biomarker data; Platform as a service (PaaS) services featuring computer software platforms to gather, compile, analyze, authenticate, validate, control, protect, exchange, and modify genetic, genomic, molecular, and biomarker data; Providing browser-based online non-downloadable computer software for use in management of genetic, genomic, molecular, and biomarker data; Platform as a service (PaaS) services featuring computer software platforms for the collection, use, or exchange of genetic, genomic, molecular, and biomarker data; Providing a website featuring scientific information on DNA data; Providing software as a service (SaaS) services featuring software for employing genetic algorithms and deep learning techniques in the fields of nucleic acid sequencing, genotyping, genetic testing, and genetics; Online non-downloadable software for reporting and analyzing data in the fields of nucleic acid sequencing, genotyping, genetic testing, and genetics; Application service provider featuring application programming interface (API) software for reporting and analyzing data in the fields of nucleic acid sequencing, genotyping, genetic testing, and genetics; Development of proprietary bioinformatic analysis software pipelines and computer systems for collecting, storing, characterizing, sorting, viewing, and delivering genetic information; Providing scientific research data in the field of genomics, including custom, proprietary bioinformatic analysis of data generated by NGS technology or unanalyzed biological data; Providing temporary use of online, non-downloadable computer software for use in laboratory information management; Providing temporary use of online non-downloadable software for laboratory workflow process automation, open database modeling, and integrating multiple data sources; Providing temporary use of online non-downloadable computer software for storage, organization, processing, retrieval and output of sampling and testing information; Computer services, namely, cloud hosting provider services in the fields of laboratory information management, laboratory information management systems and laboratory information technology; Technical support in the nature of troubleshooting of computer software problems and consulting thereto in the fields of virtualization technologies for use in laboratories, laboratory information management, laboratory information management systems and laboratory information technology; Online Non-downloadable software for use in proprietary bioinformatic analysis software pipelines and computer systems for use in the fields of nucleic acid sequencing, genotyping, genetic testing, and genetics; Online non-downloadable software for building and customizing workflows in the fields of nucleic acid sequencing, genotyping, genetic testing, and genetics; Online non-downloadable software for use in aggregating and querying large data sets in the fields of nucleic acid sequencing, genotyping, genetic testing, and genetics; Online non-downloadable software that utilizes AI (artificial intelligence) or ML (machine learning) algorithms for use in the fields of nucleic acid sequencing, genotyping, genetic testing, and genetics; Online non-downloadable cloud-based software that combines genomic knowledge and AI based optimization with a genomic database for use in the fields of nucleic acid sequencing, genotyping, genetic testing, and genetics; Providing temporary use of online, non-downloadable computer software using artificial intelligence algorithms and machine learning to support platforms that contain genetic and genomic information; Providing on-line non-downloadable software incorporating artificial intelligence and machine learning models for collecting, analyzing, assessing, interpreting and predicting genetic and genomic data or information; Providing online non-downloadable software for retrieval and correlation of genetic or genomic data; Software as a service (SaaS) services featuring software for analyzing and visualizing genetic or genomic data; Providing online non-downloadable software for use in genetic sequencer integration; Providing online non-downloadable software for use in genetic sequencer integration and for use in integrating third-party software into a single workflow; Providing online non-downloadable software for analyzing genetic code for use in an integrated data science environment; Providing online non-downloadable software to analyze, manage, aggregate, mine, and explore genetic or genomic data; Providing online non-downloadable software in the nature of a modular, secure data platform for scalable multi-omics data management, analysis, and exploration; Providing online, non-downloadable cloud-based data management and analysis software platform that enables researchers to manage, analyze, and interpret large volumes of multi-omics data in a secure, scalable, and adaptable environment; Providing online non-downloadable software for use in streamlining genomics workflow; Providing online non-downloadable software that provides users with scalable data analysis for use in the fields of nucleic acid sequencing, genotyping, genetic testing, and genetics; Providing online non-downloadable software that supports highly automated workflows and custom solutions for optimized high-throughput studies for use in the fields of nucleic acid sequencing, genotyping, genetic testing, and genetics; Providing online non-downloadable data aggregation and data science software for use in the fields of nucleic acid sequencing, genotyping, genetic testing, and genetics; Providing online non-downloadable omics software used for exploring large genomic data sets and discovering insights related to said data sets; Providing online non-downloadable software for analyzing genetic code for use in the fields of nucleic acid sequencing, genotyping, genetic testing, and genetics that provides secure data management; Providing online non-downloadable software that provides data residency, single sign-on, audit logs, and access control capabilities for use in the fields of nucleic acid sequencing, genotyping, genetic testing, and genetics | ACTIVE | Jan 28, 2021 |
| 044 | Providing online computer databases featuring genetic, genomic, molecular, and biomarker medical data; Providing online searchable databases containing medical, pharmaceutical, biological, clinical and genomic information for medical diagnostic or treatment purposes; Nucleic acid sequencing and analysis services for medical, agriculture, horticulture, veterinary, and husbandry purposes; Genome sequencing and analysis services for medical, agriculture, horticulture, veterinary, and husbandry purposes; Medical genetic analysis and reporting services thereto for medical diagnostic, prognostic or treatment uses; DNA, nucleic acid and genomic sequencing, and analysis services for medical purposes; Genetic analysis and reporting services for medical purposes; DNA analysis services for the identification and treatment of disease; Providing an online portal featuring educational, medical information in the fields of nucleic acid sequencing, genotyping, genetic testing, and genetics; Providing online computer databases featuring medical information based on the results of genetic testing; Providing a website featuring medical information on DNA data | ACTIVE | Jan 28, 2021 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Illumina, Inc.
- Other trademarks owned by Illumina, Inc.
- Other trademarks owned by Illumina, Inc.
- Other trademarks in Class 035
- Other trademarks in Class 037
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named CONNECTED ANALYTICS
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 29, 2025 | EWAF | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | — |
| Oct 29, 2025 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Oct 29, 2025 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 29, 2025 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Oct 29, 2025 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Oct 29, 2025 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Jan 7, 2025 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Jan 7, 2025 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Dec 19, 2024 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | — |
| Dec 19, 2024 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Oct 27, 2024 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Oct 27, 2024 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Aug 23, 2024 | IUAF | USE AMENDMENT FILED | — |
| Aug 23, 2024 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Mar 12, 2024 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jan 16, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jan 16, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 27, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Dec 11, 2023 | EXPT | EXPARTE APPEAL TERMINATED | — |
| Dec 11, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Dec 11, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 11, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 6, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 16, 2023 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Oct 16, 2023 | EXPI | EX PARTE APPEAL-INSTITUTED | — |
| Oct 16, 2023 | JURT | JURISDICTION RESTORED TO EXAMINING ATTORNEY | — |
| Oct 16, 2023 | EXAF | EXPARTE APPEAL RECEIVED AT TTAB | — |
| Jul 15, 2023 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Jul 15, 2023 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jul 15, 2023 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jun 22, 2023 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Jun 21, 2023 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Dec 5, 2022 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Apr 29, 2022 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Apr 29, 2022 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Apr 29, 2022 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Mar 31, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 31, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 31, 2022 | ALIE | ASSIGNED TO LIE | — |
| Mar 28, 2022 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 28, 2021 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 28, 2021 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 28, 2021 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 22, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 7, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 2, 2021 | NWAP | NEW APPLICATION ENTERED | — |